Pseudoarthrosis, or nonunion, may lead to increased patient morbidity such as continued pain, segmental instability, and need for revision surgery. Additionally, revision surgeries following the development of a pseudoarthrosis are costly to the health care system, averaging $41 631 per revision. 8 Pseudoarthrosis can develop for multiple reasons including, but not limited to, biomechanical failure of an implant, inadequate fusion bed preparation, infection of the fusion site, or biological failure of the bone. Thus, advances in surgical techniques and graft advancements are being actively investigated in order to reduce the rates of pseudoarthrosis.
Currently, autogenous bone graft (autograft) harvested from the iliac crest, commonly known as an iliac crest bone graft (ICBG), remains the gold standard for augmenting spinal fusion. 9 Although ICBG demonstrates high fusion rates, its use is hampered by donor site morbidity and limited supply-particularly for multilevel fusions. [9] [10] [11] Thus, there is a need for a bone graft alternative that can be clinically available in large quantities, provide ample bone formation, and subsequently result in low pseudoarthrosis rates and limited adverse side effects.
In spinal fusion, new bone formation has been previously described to occur via intramembranous and endochondral ossification-processes similar to long bone fracture healing. 10, [12] [13] [14] [15] [16] The key cellular mediator of endochondral ossification is the hypertrophic chondrocyte. 17 Along with their unique ability to survive in hypoxia, hypertrophic chondrocytes induce neovascularization and ossification through the release of vascular endothelial growth factor (VEGF), vesicles of hydroxyapatite, and bone-morphogenic proteins (BMPs). 5, [17] [18] [19] For these reasons, we hypothesize that hypertrophic chondrocytes offer a potential graft alternative for promoting spinal fusion. To test this hypothesis, hypertrophic chondrocytes were har- 
| MATERIALS AND METHODS
All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Vanderbilt University Medical Center (M1600140).
| Graft harvesting (FCCG and ICBG)
Male C57BL/6J mice were purchased from Jackson Laboratory and housed at Vanderbilt University in a 12-h light/dark cycle with food and water provided ad libitum. Following adequate anesthesia and analgesia, a 10 to 12 mm long medial incision was made to expose the mid-shaft of the femur. The femur was then fractured in a controlled manner by scoring the bone with a beaver blade before inducing a clean break. The transverse fracture was stabilized with the intramedullary placement of a 30-gauge needle, to induce a larger soft-tissue fracture callus, as compared with needles of a larger size (23G) with more stiffness (unpublished results); thereby allowing for a more efficient harvest.
The incision was then closed using 5-0 nylon sutures. Mice received analgesics every 12 h for 3 days following the fracture procedure to minimize pain and discomfort. Ten days following the fracture, when the soft-tissue callus was largest and amply expressing VEGF (Figure 2 ), the mice were sacrificed by CO 2 inhalation. At this time, the FCCG was harvested, along with an ICBG, for the subsequent transplantation into the posterolateral spine of syngeneic mice. Harvested grafts were standardized by volume and a 2 × 2 × 2-mm section was obtained for implantation.
| Murine posterolateral spinal bone formation model
The purpose of this surgery model was to determine the capacity of FCCG or ICBG to promote bone formation following implantation to the posterolateral lumbar spine. Immediately following FCCG and 
| Microcomputed tomography (μCT) analysis
To further assess bone formation qualitatively, mice were sacrificed 6 weeks postsurgery and 3-dimensional (3D) renderings of the posterior lumbar region were generated using μCT (μCT 40, Scanco Medical AG, Bassersdorf, Switzerland). μCT images of the spine from the thoracic to the sacral region were acquired using a polychromatic All microscopic images were obtained on a Zeiss Axio Imager A.1 (ZEISS, Oberkochen, Germany).
| Statistical analysis
Inter-and intraobserver variability, for quantification of calcification surrounding the transverse processes, was assessed using kappa statistics and interpreted with the Landis and Koch criteria. cytes. 12, 16, 30, 31 This process has the advantage of being highly angiogenic, 17, 28, 32 while taking place through a progression of mesenchymal stem cell differentiation, vascularization, and mineralization. 17, 18 Conveniently, these hypertrophic chondrocytes, for the sake of analogy, can be considered a conceptual "bone graft vesicle," containing many of the necessary factors (ie, VEGF, BMP, and hydroxyapatite) to promote new bone formation in an area of relative hypoxia. To be sure, such factors are also present in iliac crest bone graft. In the present study, our findings suggest that hypertrophic chondrocytes may be used to induce bone formation in the spine.
Recently, rat studies have established the feasibility and efficacy of hypertrophic chondrocytes to induce new bone formation in tibial defects. Bahney et al showed that cartilage, isolated from a healing fracture callus, was effective at inducing vascularized bone formation in 2 mm defects of the tibia-confirmed by μCT and histology. 32 The cartilage grafts in this previous study were shown to be equally as effective as the autograft, and superior to the allograft, in terms of both fusion rate and fusion strength. In this current study, a similar hypothesis was employed, and we found that hypertrophic chondrocytes augmented paraspinous bone formation comparable to standard ICBG. While the purpose of this study was not to assess the mechanism of bone formation (intramembranous vs endochondral ossification), use of this model in future studies in combination with lineage tracing experiments may prove insightful.
Although the findings of the current study provide a foundation for advancement in bone graft biologics, they are not without limitation. Primarily, the murine model utilized here is not directly applicable to human anatomy and/or physiology, and thus, directly extrapolating these results to human spinal fusion is not plausible.
Rather, the findings here serve to establish the proof-of-concept foundation for potential transition to small and larger animal studies. Figure S1 ). Points represent mean score between 3 reviewers per mouse AESD. N = 10 mice per experimental group. *Statistical significance between ICBG or FCCG and sham. **P < 0.01, ***P < 0.001, ****P < 0.0001. Alpha = 0.05. No statistical difference between experimental groups was detected at any time point. (C) in vivo fluorescent imaging of bone deposition using Osteosense 800 with or without mechanical stability. If these results are recapitulated, investigations into the therapeutic potential of hypertrophic chondrocytes to augment bone formation clinically may be warranted.
